Salamanders are an important ecological component of eastern hardwood forests and may be affected by natural or silvicultural disturbances that alter habitat structure and associated microclimate. From May to August in 2008 (pretreatment) and 2011 (post-treatment), we evaluated the response of salamanders to three silvicultural practices designed to promote oak regeneration — prescribed fire, midstory herbicide application and shelterwood harvest — and a control. We trapped salamanders using drift fences with pitfall traps in five replicates of the four treatments. Only the southern gray-cheeked salamander Plethodon metcalfi and the southern Appalachian salamander P. teyahalee were captured in sufficient numbers for robust statistical analysis. We analyzed data for these species using single-species dynamic occupancy models in statistical software program R. We allowed changes in four covariates to influence extinction probability from pre- to post-treatment implementation: 1) percent leaf litter cover; 2) percent understory cover; 3) percent CWD cover; and 4) percent canopy cover. The final combined model set describing extinction probability contained four models with ΔAIC < 2 for P. metcalfi and nine models with ΔAIC < 2, including the null model, for P. teyahalee. For both species, the 95% confidence intervals for model-averaged extinction probability parameter estimates overlapped zero, suggesting none were significant predictors of extinction probability. Absence of short-term salamander response in midstory herbicide and prescribed burn treatments was likely because of minor or transitory changes to forest structure. In shelterwood harvests, any potential effects of reduced canopy and leaf litter cover may have been mitigated by rapid post-treatment vegetation sprouting. Additionally, climatic conditions associated with high elevation sites and high amounts of rainfall in 2011 may have compensated for potential changes to microclimate. Continued monitoring of Plethodon salamanders to assess responses at longer time scales (e.g. > 3 years post-treatment) is warranted.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.